Novozymes went slightly up except for one division

The biofuel division was the only part of Novozymes to suffer a setback in 2016, according to the annual report on a "challenging year", in which the enzyme producer kicks off a round of firings and a large-scale share buy-back program.

BY MAZ PLECHINGER

Published: 18.01.17 at 10:17

Overall, Novozymes made progress in 2016. The enzyme producer's revenue increased slightly by 1 percent to DKK 14,142 million (EUR 1,902 million) while the result landed a good 7 percent above 2015 at DKK 3,881 before taxes, according to the annual report presented Wednesday morning.

However, the progress is not a result of positive trends in the biofuel business. As the only one of Novozyme's five divisions, it suffered an unsurprising setback with revenue of DKK 2,438 million, which is 4 percent less than the previous year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

Access all locked articles
Receive our daily newsletters
Access our app

Start a free company trial today

Vestas awaits clarity on major US green energy funding

Henrik Andersen, adm. direktør for Vestas. | Foto: Saxo Bank // PR

After a second quarter that, to put it mildly, was disappointing on order intake, the Danish wind turbine manufacturer intends to maintain its price strategy. Major green energy funding from the US spells promise, but Vestas is waiting for final clarity.